Double attack on advanced prostate cancer: radiation meets immune vaccine
NCT ID NCT07219147
Summary
This early-stage study is testing if combining two different treatments is safe and works better than one alone for advanced prostate cancer. One treatment is a targeted radiation drug that seeks out and kills cancer cells. The other is a personalized vaccine designed to train the patient's own immune system to attack the cancer. The study will enroll about 30 men to see if the combination is safe and triggers a stronger immune response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IVB PROSTATE CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
City of Hope Medical Center
RECRUITINGDuarte, California, 91010, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.